Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - joyce+schroeder
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Inhibition of Metastasis in Triple Negative Breast Cancer
This invention uses a therapeutic peptide sequence that inhibits breast cancer metastasis by activating natural killer (NK) cells against breast cancer cells. This inhibitor can be used to treat triple-negative breast cancer metastasis, associated with excess epidermal growth factor receptor (EGRF) which is overexpressed and amplified in 60% of triple-negative...
Published: 1/21/2026
|
Inventor(s):
Joyce Schroeder
Keywords(s):
Category(s):
Technology Classifications > Healthcare Portfolios > Oncology
,
Technology Classifications > Healthcare Portfolios > Women's Health
,
Technology Classifications > Life Sciences > Therapeutics
Peptide Therapeutic for Immune Response Activation against Metastatic Triple Negative Breast Cancer
This invention provides compositions and methods for treating triple negative breast cancer using peptides or peptide mimics that bind to epidermal growth factor receptor (EGFR) to block EGFR nuclear translocation. This mode of action alters EGFR-dependent gene transcription, induces the loss of cancer cell survival and migratory capacity, and...
Published: 3/12/2024
|
Inventor(s):
Joyce Schroeder
,
Angelica Escoto
,
Benjamin Atwell
Keywords(s):
Category(s):
Technology Classifications > Healthcare Portfolios > Oncology
,
Technology Classifications > Life Sciences > Therapeutics
Peptide Therapeutic for Triple Negative Breast Cancer
This invention provides compositions and methods for treating breast cancer using peptides or peptide mimics that bind to epidermal growth factor receptor (EGFR) and block transport of EGFR to cell nuclei. This mode of action results in loss of cancer cell survival and migratory capacity and induces tumor regression. This therapeutic induces cell death...
Published: 3/12/2024
|
Inventor(s):
Joyce Schroeder
,
Benjamin Atwell
Keywords(s):
Category(s):
Technology Classifications > Healthcare Portfolios > Oncology
,
Technology Classifications > Life Sciences > Therapeutics